Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer

被引:12
作者
Diniz Bizzo, Solange Maria
Meira, Debora Dummer [1 ]
Lima, Jose Marinaldo
Mororo, Janio da Silva [1 ]
Casali-da-Rocha, Jose Claudio
Faria Ornellas, Maria Helena [2 ]
机构
[1] Univ Estado Rio De Janeiro, Dept Biochem, Rio De Janeiro, Brazil
[2] Univ Estado Rio De Janeiro, Dept Pathol, Rio De Janeiro, Brazil
关键词
Angiogenesis; Ovarian cancer; Prognosis; Vascular endothelial growth factor; ENDOTHELIAL GROWTH-FACTOR; FACTOR EXPRESSION; SURVIVAL; ANGIOGENESIS; PROGRESSION; NEOPLASMS; DISEASE;
D O I
10.1016/j.ijgo.2009.11.021
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether peripheral plasma concentration, peritoneal fluid concentration, and/or peritoneal vascular endothelial growth factor (VEGF) burden can predict the possibility of optimal cytoreduction in women with epithelial ovarian carcinoma (EOC); and if so, to determine cutoff values below which optimal cytoreduction is likely to occur. Methods: We measured plasma VEGF concentration, peritoneal VEGF concentration, and VEGF burden in 46 women undergoing cytoreductive surgery. Univariate analysis, bivariate analysis, correlation tests, and stepwise regression were performed with cytoreduction as the outcome. Results: The VEGF burden best predicted the outcome. The area under the curve was 0.84 and the log-transformed cutoff value was 15.52 log pg. Overall, the chance of optimal cytoreduction was 11 times greater when the VEGF burden was less than 15.52 log pg. For women with advanced disease, the chance was 6 times greater below this value. Conclusion: The VEGF burden may quantify tumor activity, and it could be used when selecting patients likely to benefit from induction chemotherapy before undergoing cytoreductive surgery. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:113 / 117
页数:5
相关论文
共 25 条
[11]  
Kraft A, 1999, CANCER-AM CANCER SOC, V85, P178
[12]   Surgical Stress Promotes Tumor Growth in Ovarian Carcinoma [J].
Lee, Jeong-Won ;
Shahzad, Mian M. K. ;
Lin, Yvonne G. ;
Armaiz-Pena, Guillermo ;
Mangala, Lingegowda S. ;
Han, Hee-Dong ;
Kim, Hye-Sun ;
Nam, Eun Ji ;
Jennings, Nicholas B. ;
Halder, Jyotsnabaran ;
Nick, Alpa M. ;
Stone, Rebecca L. ;
Lu, Chunhua ;
Lutgendorf, Susan K. ;
Cole, Steve W. ;
Lokshin, Anna E. ;
Sood, Anil K. .
CLINICAL CANCER RESEARCH, 2009, 15 (08) :2695-2702
[13]   Role of vascular endothelial growth factor in ovarian cancer -: Inhibition of ascites formation by immunoneutralization [J].
Mesiano, S ;
Ferrara, N ;
Jaffe, RB .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1249-1256
[14]   Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant and nomalignant ascites [J].
Nascimento, I ;
Schaer, R ;
Lemaire, D ;
Freire, S ;
Paule, B ;
Carvalho, S ;
Meyer, R ;
Schaer-Barbosa, H .
APMIS, 2004, 112 (09) :585-587
[15]   Potential predictors of chemotherapy response in ovarian cancer - How do we define chemosensitivity? [J].
O'Toole, S. A. ;
Sheppard, B. L. ;
Laios, A. ;
O'Leary, J. J. ;
McGuinness, E. P. J. ;
D'Arcy, T. ;
Bonnar, J. .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :345-351
[16]   Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia [J].
Obermair, A ;
BancherTodesca, D ;
Bilgi, S ;
Kaider, A ;
Kohlberger, P ;
MullauerErtl, S ;
Leodolter, S ;
Gitsch, G .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (16) :1212-1217
[17]  
OZOLS RF, 2005, PRINCIPLES PRACTICE, P825
[18]   Angiogenesis in gynecological oncology - mechanism of tumor progression and therapeutic targets [J].
Rasila, KK ;
Burger, RA ;
Smith, H ;
Lee, FC ;
Verschraegen, C .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (05) :710-726
[19]   Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up [J].
Rudlowski, C ;
Pickart, AK ;
Fuhljahn, C ;
Friepoertner, T ;
Schlehe, B ;
Biesterfeld, S ;
Schroeder, W .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :183-189
[20]   The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer [J].
Secord, AA ;
Sayer, R ;
Synder, SA ;
Broadwater, G ;
Rodriguez, GC ;
Berchuck, A ;
Blackwell, K .
GYNECOLOGIC ONCOLOGY, 2004, 94 (01) :74-79